NCT00205179View on ClinicalTrials.gov

Alzheimer's Disease: Potential Benefit of Isoflavones

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Alzheimer's Disease
Interventions
DRUG

Novasoy

100mg/day soy isoflavones

DRUG

Placebo

100mg/day matching placebo

Trial Locations (1)

53792

University of Wisconsin, Madison

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute on Aging (NIA)

NIH

lead

University of Wisconsin, Madison

OTHER

NCT00205179 - Alzheimer's Disease: Potential Benefit of Isoflavones | Biotech Hunter | Biotech Hunter